Clinical Trial

Outcomes After Liver and Biliary Resection at a High-Volume Center

Study acronym: BILIVER
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to evaluate clinical and oncologic outcomes in adult patients undergoing liver and/or biliary resection for benign and malignant diseases. This study evaluates postoperative morbidity and mortality within 90 days after surgery, as well as overall survival and disease-free survival in patients with malignant disease. Participants will: * undergo standard surgical and perioperative management according to routine clinical practice * have clinical, surgical, and follow-up data collected from institutional medical records * be followed for postoperative outcomes and long-term oncologic outcomes up to 5 years
Trial Details
NCT Number NCT07556835
Lead Sponsor Azienda USL Toscana Centro
Conditions Liver Neoplasms, Hepatobiliary Diseases, Cholangiocarcinoma, Hepatocellular Carcinoma, Liver Metastases From Colorectal Cancer, Liver Metastases, Biliary Tract Diseases, Benign Liver Disease +1 more
Enrollment 1,000 participants
Start Date 2026-04
Primary Completion 2036-01 (estimated)
Study Completion 2036-12 (estimated)
Updated on ClinicalTrials.gov 2026-04-29